CINA-iPE

Avicenna.AI
The CINA-iPE solution provides automated detection and prioritization of incidental Pulmonary Embolism on CTA scans.
avicenna-cina-chest-ipe.png
Information source: Vendor
Last updated: November 19, 2024

General Information

General
Product name CINA-iPE
Company Avicenna.AI
Subspeciality Chest
Modality CT
Disease targeted Pulmonary embolism
Key-features Pulmonary embolism detection, notification
Suggested use Before: adapting worklist order, flagging acute findings

Technical Specifications

Data characteristics
Population Patient with CTA scan ordered for indications other than suspected PE
Input Chest and thoraco-abdominal CT angiographies (CTA)
Input format DICOM
Output bounding box, worklist order, notification
Output format DICOM SC, GSPS
Technology
Integration Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based
Trigger for analysis Automatically, right after the image acquisition
Processing time 10 - 60 seconds

Regulatory

Certification
CE
Certified, Class IIb , MDR
FDA 510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)

Market

Market presence
On market since 02-2023
Distribution channels Eureka Clinical AI, Blackford, Contextflow
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Pay-per-use, Subscription
Based on Number of installations, Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
  • Contribution of an artificial intelligence tool in the detection of incidental pulmonary embolism on oncology assessment scans (read)

  • Performance and clinical utility of an artificial intelligence-enabled tool for pulmonary embolism detection (read)
Non-peer reviewed papers on performance
Other relevant papers